Guardant Health (GH) PT Raised to $200 at RBC Capital

July 31, 2026 8:15 AM

RBC Capital analyst Dan Leonard raised the price target on Guardant Health (NASDAQ: GH) to $200.00 (from $185.00) while maintaining a Outperform rating.

No results found